Key facts
- A "blood signature" may predict lung cancer risk more than five years before diagnosis.
- This discovery offers a potential pathway to earlier prevention.
A newly identified "blood signature" may predict lung cancer risk more than five years before diagnosis, offering a potential pathway to earlier prevention, according to a study. The findings suggest that this marker could be used to identify individuals at high risk for lung cancer well in advance of clinical diagnosis.